Literature DB >> 10720804

CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes.

L S Tzouvelekis1, E Tzelepi, P T Tassios, N J Legakis.   

Abstract

CTX-M-type beta-lactamases constitute a novel group of class A beta-lactamases with extended-spectrum properties. They are encoded by transferable plasmids and found in various enterobacteria, mostly Salmonella typhimurium, Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. CTX-M enzymes share extensive sequence similarity with the chromosomal beta-lactamases of Klebsiella oxytoca. They efficiently hydrolyze many newer broad-spectrum oximino-beta-lactams including cefotaxime, ceftriaxone and aztreonam and are readily inhibited by tazobactam and clavulanate. CTX-M-producing enterobacteria are endemic in Latin America and in some areas of North Eastern Europe. Data on their structure, properties and epidemiology are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720804     DOI: 10.1016/s0924-8579(99)00165-x

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  93 in total

1.  What's New in beta-lactamases?

Authors:  Patricia A. Bradford
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

2.  Characterization of a chromosomally encoded extended-spectrum class A beta-lactamase from Kluyvera cryocrescens.

Authors:  J W Decousser; L Poirel; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

3.  Biochemical-genetic characterization of the chromosomally encoded extended-spectrum class A beta-lactamase from Rahnella aquatilis.

Authors:  S Bellais; L Poirel; N Fortineau; J W Decousser; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

4.  Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland.

Authors:  Anna Baraniak; Janusz Fiett; Agnieszka Sulikowska; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

5.  Plasmidic extended-spectrum beta-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina.

Authors:  Alejandro Petroni; Alejandra Corso; Roberto Melano; María Luisa Cacace; Ana María Bru; Alicia Rossi; Marcelo Galas
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

6.  Cloning and expression of class A beta-lactamase gene blaA(BPS) in Burkholderia pseudomallei.

Authors:  Terence K M Cheung; P L Ho; Patrick C Y Woo; K Y Yuen; P Y Chau
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

Review 7.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

8.  Molecular characterization of a novel plasmid-encoded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya.

Authors:  S Kariuki; J E Corkill; G Revathi; R Musoke; C A Hart
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

9.  Characterization of IncA/C conjugative plasmid harboring bla TEM-52 and bla CTX-M-15 extended-spectrum β-lactamases in clinical isolates of Escherichia coli in Tunisia.

Authors:  C Chouchani; A El Salabi; R Marrakchi; L Ferchichi; T R Walsh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-22       Impact factor: 3.267

10.  Dissemination of multiple drug resistance genes by class 1 integrons in Klebsiella pneumoniae isolates from four countries: a comparative study.

Authors:  Piklu Roy Chowdhury; Ana Ingold; Natasha Vanegas; Elena Martínez; John Merlino; Andrea Karina Merkier; Mercedes Castro; Gerardo González Rocha; Graciela Borthagaray; Daniela Centrón; Helia Bello Toledo; Carolina M Márquez; H W Stokes
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.